Amyotrophic lateral sclerosis natural history, complications and prognosis
Amyotrophic lateral sclerosis Microchapters |
Differentiating Amyotrophic lateral sclerosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Amyotrophic lateral sclerosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Amyotrophic lateral sclerosis natural history, complications and prognosis |
FDA on Amyotrophic lateral sclerosis natural history, complications and prognosis |
CDC on Amyotrophic lateral sclerosis natural history, complications and prognosis |
Amyotrophic lateral sclerosis natural history, complications and prognosis in the news |
Blogs on Amyotrophic lateral sclerosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Natural History, Complications, and Prognosis
Natural History
- The symptoms of Amyotrophic lateral sclerosis usually develop in the fifth decade of life.[1]
- Only 5% of the cases have an onset <30 years of age.[1]
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ 1.0 1.1 Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD; et al. (2008). "Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues". J Neurol Neurosurg Psychiatry. 79 (1): 6–11. doi:10.1136/jnnp.2006.104828. PMID 18079297.